Dudediligence.

Johnson & Johnson

JNJNYSE · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$156.1M

18 notices · 637,169 sh

Oct 2025 to Oct 2026

Reported ·

$87.1M

19 sales · 1 buy · $257,688 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

None of the 19 reported sales carry the 10b5-1 box. Together they are 0.02% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-02: Schmid Timothy, Form 1442026-08-17: Taubert Jennifer L, Form 1442026-08-13: Duato Joaquin, Form 1442026-08-06: Forminard Elizabeth, Form 1442026-08-05: Joaquin Duato, Form 1442026-07-20: Broadhurst Vanessa, Form 1442026-06-11: Wengel Kathryn E, Form 1442026-02-27: Decker Robert J, Form 1442026-02-20: Schmid Timothy, Form 1442026-02-18: Schmid Timothy, Form 1442026-02-17: Broadhurst Vanessa, Form 1442026-02-17: Swanson James D., Form 1442026-02-17: Wolk Joseph J, Form 1442026-02-17: REED JOHN C, Form 1442026-02-13: Swanson James D., Form 1442026-02-05: Forminard Elizabeth, Form 1442026-01-26: Joaquin Duato, Form 1442025-10-17: REED JOHN C, Form 1442025-10-17: REED JOHN C, sold2025-11-26: MORIKIS JOHN G, bought2026-01-26: Duato Joaquin, sold2026-02-13: Swanson James D., sold2026-02-17: Broadhurst Vanessa, sold2026-02-17: REED JOHN C, sold2026-02-17: Wolk Joseph J, sold2026-02-18: Schmid Timothy, sold2026-02-20: Schmid Timothy, sold2026-02-27: Decker Robert J, sold2026-06-11: Wengel Kathryn E, sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-09-02Schmid Timothy, EVP, WW Chair, MedTech$9,230,440
33,597 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-17Taubert Jennifer L, EVP, WWC. Innovative Medicine$3,950,418
15,000 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-13Duato Joaquin, CEO and Chairman of the Board$32.2M
123,291 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-06Forminard Elizabeth, EVP, Chief Legal Officer$4,090,957
15,918 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-05Joaquin Duato, CEO and Chairman of the Board$12.4M
48,480 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-20Broadhurst Vanessa, EVP, Global Corp Affairs$5,792,689
23,054 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-11Wengel Kathryn E, EVP, Chief TO and Risk Officer$2,401,539
10,000 shno plan date144 ↗
Form 4, 2026-06-12: sold 10,000 at $241.15 Form 4 ↗
2026-02-27Decker Robert J, VP Corporate Controller$1,010,070
4,075 shno plan date144 ↗
Form 4, 2026-03-03: sold 4,075 at $247.87 Form 4 ↗
2026-02-20Schmid Timothy, EVP, WW Chair, MedTech$324,763
1,322 shno plan date144 ↗
Form 4, 2026-02-23: sold 1,322 at $245.66 Form 4 ↗
2026-02-18Schmid Timothy, EVP, WW Chair, MedTech$5,527,546
22,623 shno plan date144 ↗
Form 4, 2026-02-18: sold 22,623 at $244.33 Form 4 ↗
2026-02-17Broadhurst Vanessa, EVP, Global Corp Affairs$1,508,300
6,197 shno plan date144 ↗
Form 4, 2026-02-18: sold 6,197 at $243.39 Form 4 ↗
2026-02-17Swanson James D., EVP, CIO$4,980,510
20,521 shno plan dateno Form 4 on file144 ↗
2026-02-17Wolk Joseph J, Exec VP, CFO$21.8M
89,654 shno plan date144 ↗
Form 4, 2026-02-18: sold 89,654 at $242.80 Form 4 ↗
2026-02-17REED JOHN C, EVP, Innovative Medicine, R&D$13.1M
53,931 shno plan date144 ↗
Form 4, 2026-02-18: sold 53,931 at $243.00 Form 4 ↗
2026-02-13Swanson James D., EVP, CIO$10.1M
41,559 shno plan date144 ↗
Form 4, 2026-02-18: sold 62,080 at $243.39 Form 4 ↗
2026-02-05Forminard Elizabeth, EVP, Chief Legal Officer$1,481,195
6,226 shno plan dateno Form 4 on file144 ↗
2026-01-26Joaquin Duato, CEO and Chairman of the Board$22.0M
100,000 shno plan date144 ↗
Form 4, 2026-01-28: sold 100,000 at $221.23 Form 4 ↗
2025-10-17REED JOHN C, EVP, Innovative Medicine, R&D$4,185,794
21,721 shno plan date144 ↗
Form 4, 2025-10-20: sold 21,721 at $192.71 Form 4 ↗